The antileishmanial activity of lapachol, isolapachol, and dihydrolapachol, along with soluble derivatives (potassium salt) and acetate was obtained. All the compounds were assayed against metacyclic promastigotes of two different species of Leishmania associated to tegumentar leishmaniasis: L. amazonensis and L. braziliensis. All compounds presented significant activity, being isolapachol acetate the most active against promastigotes, with IC 50/24h = 1.6 ± 0.0 μg/ml and 3.4 ± 0.5 μg/ml for, respectively, L. amazonensis and L. braziliensis. This compound was also assayed in vivo against L. amazonensis and showed to be active. Its toxicity in vitro was also established, and at concentration similar to the IC50, no toxicity was evidenced. In all experiments, pentamidine isethionate was used as a reference drug. The present results reinforce the potential use of substituted hydroxyquinones and derivatives as promising antileishmanial drugs and suggest a continuing study within this class of compounds.
CITATION STYLE
Lima, N. M. F., Correia, C. S., Leon, L. L., Machado, G. M. C., De Fátima Madeira, M., Santana, A. E. G., & Goulart, M. O. F. (2004). Antileishmanial activity of lapachol analogues. Memorias Do Instituto Oswaldo Cruz, 99(7), 757–761. https://doi.org/10.1590/S0074-02762004000700017
Mendeley helps you to discover research relevant for your work.